Clinical Trials Logo

Pancreatic Cancer Stage IVA clinical trials

View clinical trials related to Pancreatic Cancer Stage IVA.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00869258 Completed - Clinical trials for Pancreatic Cancer Stage IVA

Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar

Start date: June 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether an experimental drug combination consisting of Gemzar®, Taxotere®, and Xeloda®, (called GTX) when followed by radiation therapy plus low-dose Gemzar, is safe and effective in treating advanced pancreatic cancer and to study and enhance the utility of PET scans in the evaluation of patients with pancreatic cancer.